期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
TCM therapy for patients with positive antibody response to SARS-CoV-2
1
作者 Chang-Ming Chen Wei-Jing Wang +2 位作者 Man Wang Li Hai Xiao-Nan Wang 《Drug Combination Therapy》 2023年第2期40-43,共4页
Objective:This study aimed to observe the efficacy and safety of traditional Chinese medicine therapy in patients with positive antibody responses to severe acute respiratory syndrome coronavirus 2.Methods:A retrospec... Objective:This study aimed to observe the efficacy and safety of traditional Chinese medicine therapy in patients with positive antibody responses to severe acute respiratory syndrome coronavirus 2.Methods:A retrospective observation was conducted on 25 patients with positive antibody responses but negative nucleic acid testing results who received Anshouxinshen therapy.The changes in symptoms,infective indicators,and safety were recorded.Results:Following treatment,the positive IgM responses of 18 patients became negative within one week,with an average time for antibody to become negative being 2 days.Of the seven patients with positive IgG responses,six became IgG-negative with an average time for antibody to become negative being 6.8 days.All symptoms of anxiety,insomnia,cough,fever,fatigue,and other symptoms improved 100%for all patients.After treatment,the lymphocyte count and lymphocyte ratio of patients significantly increased.No adverse reactions to Anshouxinshen therapy were reported.Conclusion:Anshouxinshen therapy is an effective treatment for patients with positive antibody responses to syndrome coronavirus 2,safely improving their immune functions.Early traditional Chinese medicine intervention can reduce the incidence of coronavirus disease 2019 and improve its cure rate,thereby promoting the prevention and control of coronavirus disease 2019. 展开更多
关键词 COVID-19 ANTIBODY Chinese medicine anshouxinshen therapy
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部